Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› New York
Clinical trial register · United States · industry-sponsored

Clinical Trials in New York, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9148 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 21 Nov 2026, 03:16 UTC
9148
Studies in scope
industry-sponsored, all four open statuses
4975
Recruiting now
open to new participants
2181
Lead sponsors
across recruiting studies
Top states
California 117 Florida 107 Georgia 51 New York 51 Arizona 50

Trials with a site in New York

51 of 9148 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Recruiting
Pfizer
Observational
100
New York
2026-11-16
Recruiting
Pfizer
Phase 3
600
Florida, Minnesota, Nevada, New York, Ohio, Oregon, Tennessee, Texas
2026-11-05
Active, closed
A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies
NCT07897669Metastatic Urothelial Carcinoma, Urothelial Cancer, Urothelial Carcinoma, Locally Advanced or Metastatic Urothelial Carcinoma
Pfizer
Observational
5,122
New York
2026-11-04
Recruiting
Pfizer
Phase 3
1,100
Illinois, Missouri, New York, Oklahoma, Pennsylvania, Texas
2026-09-30
Active, closed
Pfizer
Observational
4,700
New York
2026-08-19
Active, closed
Pfizer
Observational
1
New York
2026-07-20
Recruiting
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
NCT07476287Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer, Lung Neoplasms
Pfizer
Phase 2
40
California, Florida, Illinois, Massachusetts, New Jersey, New York, Ohio
2026-07-02
Active, closed
Pfizer
Observational
293,334
New York
2026-06-22
Recruiting
Pfizer
Phase 2
24
Indiana, New York
2026-05-28
Active, closed
A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment
NCT07567352Non-Small-Cell Lung, ALK-positive Advanced NSCLC, ALK-positive Non-small-cell Lung Cancer, ALK-positive NSCLC
Pfizer
Observational
200
New York
2026-05-01
Recruiting
Pfizer
Phase 3
1,712
Maine, Massachusetts, New Jersey, New York, Pennsylvania, Rhode Island, Vermont, Virginia
2026-04-08
Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
NCT07227298Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer
Phase 1/2
162
Arkansas, California, Colorado, Florida, Massachusetts, New Jersey, New York, Oregon
2026-01-30
Active, closed
Pfizer
Observational
846,279
New York
2026-01-21
Recruiting
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
NCT07318805Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Colorectal Cancer, Metastatic Colorectal Adenocarcinoma
Pfizer
Phase 1
260
California, Michigan, New York, Texas, Utah
2025-12-23
Active, closed
Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants
NCT07249320Respiratory Syncytial Virus (RSV)
Pfizer
Observational
1
New York
2025-12-01
Recruiting
Pfizer
Phase 2
165
Arizona, California, Florida, New York, Ohio, Pennsylvania
2025-11-20
Active, closed
Pfizer
Phase 3
207
New Jersey, New York, Pennsylvania
2025-11-19
Recruiting
Pfizer
Phase 1
294
Alabama, Florida, Georgia, Illinois, Iowa, Kansas, New Jersey, New York
2025-11-06
Recruiting
Pfizer
Phase 2
200
Arizona, Arkansas, California, Colorado, Illinois, Maryland, Michigan, New York
2025-10-30
Active, closed
Pfizer
Phase 1
200
California, Florida, New York, Ohio, Tennessee
2025-08-11
Active, closed
Pfizer
Phase 1
380
California, Florida, Kansas, Missouri, Nebraska, New York, North Carolina, Ohio
2025-07-22
Recruiting
Pfizer
Phase 1
16
District of Columbia, Georgia, Minnesota, Nebraska, New York, North Carolina, Ohio, Oklahoma
2025-05-16
Active, closed
Pfizer
Observational
1
New York
2025-04-16
Active, closed
Pfizer
Observational
1
New York
2025-02-24
Active, closed
Pfizer
Observational
22,234,435
New York
2025-01-20
Recruiting
Pfizer
Observational
600
New York
2025-01-20
Active, closed
Pfizer
Phase 3
900
Arizona, Arkansas, California, Illinois, New York, Washington
2024-10-22
Active, closed
Pfizer
Observational
300
Arizona, California, Colorado, Florida, Illinois, Maryland, New Jersey, New York
2024-09-17
Active, closed
Pfizer
Observational
1
New York
2024-06-24
Recruiting
Pfizer
Observational
50
New York
2024-05-03
Active, closed
Pfizer
Phase 1/2
71
Arkansas, California, Colorado, Connecticut, Michigan, New Jersey, New York, Texas
2024-02-19
Active, closed
Pfizer
Phase 3
394
California, Florida, Indiana, Louisiana, Maryland, Michigan, New Mexico, New York
2024-01-19
Active, closed
Pfizer
Observational
1
New York
2023-11-01
Recruiting
Pfizer
Observational
400
New York
2023-07-25
Recruiting
Pfizer
Phase 3
318
Arizona, California, Florida, Massachusetts, Missouri, New York, Ohio, Oklahoma
2023-05-20
Recruiting
Pfizer
Phase 2
48
California, New York
2023-04-18
Active, closed
Pfizer
Phase 1/2
936
Arizona, California, Florida, Illinois, Kansas, Minnesota, Missouri, New York
2023-03-23
Recruiting
Pfizer
Phase 3
173
California, Florida, Indiana, Mississippi, New York, Pennsylvania, Washington
2022-12-28
Active, closed
Pfizer
Phase 1
103
Arkansas, Colorado, Florida, Massachusetts, Michigan, New Jersey, New York, Ohio
2022-07-05
Recruiting
Pfizer
Phase 4
210
Arizona, Georgia, Massachusetts, Minnesota, Missouri, New Jersey, New York, North Carolina
2022-07-05
Active, closed
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
NCT05160636COVID-19, Coronavirus Disease 2019, Influenza
Pfizer
Observational
999
New York
2022-01-31
Active, closed
Pfizer
Observational
1
New York
2021-12-15
Recruiting
Pfizer
Phase 3
245
Iowa, New York, Pennsylvania, Washington
2021-11-17
Recruiting
Pfizer
Phase 3
893
California, Colorado, Florida, Louisiana, New Jersey, New York
2021-10-04
Active, closed
Pfizer
Phase 3
77
Arkansas, California, Florida, New Jersey, New York, Pennsylvania, Texas, Washington
2021-09-29
Active, closed
Pfizer
Phase 3
118
California, Connecticut, Florida, Georgia, Massachusetts, New York, Ohio, Pennsylvania
2021-08-12
Active, closed
PF-07104091 as a Single Agent and in Combination Therapy
NCT04553133Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
Pfizer
Phase 2
157
Iowa, Kentucky, Massachusetts, New Jersey, New York, Virginia
2020-09-16
Active, closed
Pfizer
Phase 3
296
Florida, Massachusetts, New York, Tennessee, Washington
2017-04-27
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-usa/state/new-york

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,148 studies in total at the last sync on 21 Nov 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in New York that also match the filters currently applied.

How many clinical trials are recruiting in New York?

22 of the 51 studies on this page are recruiting new participants as of the 21 Nov 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 29 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (New York), 51 studies
PhaseStudiesRecruitingShare
Observational21441.2%
Phase 314827.5%
Phase 16311.8%
Phase 26511.8%
Phase 1/2315.9%
Phase 4112%

Most active sponsors

Lead sponsors with the most studies (New York)
Lead sponsorStudiesRecruiting
Pfizer5122
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.